Physician profile
Michael E Meegan
NPI 1073280368
$1,637.79
in general payments reported to CMS, 2019-2025
6 companies · $549 in 2025
The $549 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $438 · 2023: $479 · 2024: $172 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $662.03 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $429.17 | 2022-2025 | Precision7, Precision 1, Rocklatan |
| Bausch & Lomb Americas INC. | $390.58 | 2022-2025 | Miebo, Infuse, Vyzulta |
| Johnson & Johnson Vision Care, INC. | $112.74 | 2022-2024 | |
| Horizon Therapeutics Plc | $21.78 | 2023 | Tepezza |
| Abbvie INC. | $21.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Meegan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.